An exclusive report by The Wall Street Journal details how Microsoft unveiled OpenAI's unreleased GPT-4 to the world without ...
Kennedy Jr., a longtime and visceral critic of pharmaceutical and biotech companies, was nominated by President Trump to be ...
It's not yet been a week since Marty Makary, M.D., was confirmed to lead the FDA as its commissioner. | Peter Marks, M.D., Ph ...
Shares in Moderna, Vaxcyte, Novavax and BioNTech all fell Monday after Peter Marks, head of the FDA office that reviews ...
By Manas Mishra (Reuters) -Shares of U.S. drugmakers fell before the bell on Monday after reports that the Food and Drug ...
Commissioner Marty Makary signed off on the plan to push out the agency’s top vaccine official, Peter Marks, in one of his ...
Ouster is a high-growth LiDAR technology company with a strong balance sheet, but breakeven is still several years away. Read ...
Ouster's growth potential, competitive edge, and strong financial outlook make it a top buy, with a $27 target. Learn why ...
After the ouster of Bangladesh Prime Minister Sheikh Hasina, religious fundamentalists in one town announced that young women ...
The ice cream giant accused its parent company of removing its CEO because of his support for the brand’s activism.
Hailed for his offensive talents, he quickly became the Rangers’ top prospect after the organization drafted him No. 23 ...
On Monday, Ouster stock earned a positive adjustment to its Relative Strength (RS) Rating, from 80 to 95. IBD's proprietary RS Rating identifies technical performance by using a 1 (worst ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results